CASI Pharmaceuticals, Inc. – NASDAQ:CASI

CASI Pharmaceuticals stock price today

$2.17
-0.81
-27.18%
Financial Health
0
1
2
3
4
5
6
7
8
9

CASI Pharmaceuticals stock price monthly change

-52.17%
month

CASI Pharmaceuticals stock price quarterly change

-52.17%
quarter

CASI Pharmaceuticals stock price yearly change

-53.07%
year

CASI Pharmaceuticals key metrics

Market Cap
34.30M
Enterprise value
15.91M
P/E
-1.31
EV/Sales
0.42
EV/EBITDA
-0.66
Price/Sales
1.02
Price/Book
0.61
PEG ratio
-0.05
EPS
-2.23
Revenue
28.15M
EBITDA
-24.51M
Income
-29.86M
Revenue Q/Q
-59.15%
Revenue Y/Y
-33.57%
Profit margin
-73.17%
Oper. margin
-88.53%
Gross margin
58.51%
EBIT margin
-88.53%
EBITDA margin
-87.05%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

CASI Pharmaceuticals stock price history

CASI Pharmaceuticals stock forecast

CASI Pharmaceuticals financial statements

CASI Pharmaceuticals, Inc. (NASDAQ:CASI): Profit margin
Jun 2023 9.82M -10.23M -104.27%
Sep 2023 8.83M -4.63M -52.44%
Dec 2023 6.09M -5.46M -89.66%
Mar 2024 3.40M -9.52M -279.5%
CASI Pharmaceuticals, Inc. (NASDAQ:CASI): Analyst Estimates
Dec 2023 6.09M -5.46M -89.66%
Mar 2024 3.40M -9.52M -279.5%
Sep 2025 12.5M -6.82M -54.6%
Dec 2025 14.5M -6.28M -43.38%
  • Analysts Price target

  • Financials & Ratios estimates

CASI Pharmaceuticals, Inc. (NASDAQ:CASI): Debt to assets
Jun 2023 77874000 24.03M 30.86%
Sep 2023 74228000 23.79M 32.06%
Dec 2023 75268000 51.10M 67.89%
Mar 2024 58011000 42.54M 73.34%
CASI Pharmaceuticals, Inc. (NASDAQ:CASI): Cash Flow
Jun 2023 0 0 0
Sep 2023 0 0 0
Dec 2023 0 0 0
Mar 2024 0 0 0

CASI Pharmaceuticals alternative data

CASI Pharmaceuticals, Inc. (NASDAQ:CASI): Employee count
Aug 2023 224
Sep 2023 224
Oct 2023 224
Nov 2023 224
Dec 2023 224
Jan 2024 224
Feb 2024 224
Mar 2024 224
Apr 2024 224
May 2024 176
Jun 2024 176
Jul 2024 176

CASI Pharmaceuticals other data

17.13% -82.87%
of CASI is owned by hedge funds
2.33M -465.33K
shares is hold by hedge funds

CASI Pharmaceuticals, Inc. (NASDAQ:CASI): Insider trades (number of shares)
Period Buy Sel
Nov 2021 400000 0
Jun 2022 88154 0
Aug 2022 303723 0
Sep 2022 67794 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HUANG JAMES director
Common Stock 33,300 $4.28 $142,624
Purchase
HUANG JAMES director
Common Stock 3,111 $4 $12,435
Purchase
HUANG JAMES director
Common Stock 19,162 $3.89 $74,598
Purchase
HUANG JAMES director
Common Stock 400 $3.74 $1,496
Purchase
HUANG JAMES director
Common Stock 11,821 $3.72 $44,010
Purchase
HUANG JAMES director
Common Stock 24,975 $3.75 $93,531
Purchase
HUANG JAMES director
Common Stock 39,527 $3.75 $148,187
Purchase
HUANG JAMES director
Common Stock 5,000 $3.75 $18,750
Purchase
HUANG JAMES director
Common Stock 40,000 $3.5 $140,000
Purchase
HUANG JAMES director
Common Stock 23,105 $3.46 $80,036
Friday, 15 November 2024
accesswire.com
Thursday, 24 October 2024
accesswire.com
Wednesday, 4 September 2024
prnewswire.com
Friday, 16 August 2024
prnewswire.com
Monday, 29 July 2024
investorplace.com
Friday, 19 July 2024
prnewswire.com
Monday, 8 July 2024
prnewswire.com
Thursday, 27 June 2024
zacks.com
Wednesday, 26 June 2024
prnewswire.com
prnewswire.com
Wednesday, 15 May 2024
prnewswire.com
Tuesday, 14 May 2024
prnewswire.com
Monday, 8 April 2024
prnewswire.com
Thursday, 28 March 2024
prnewswire.com
Tuesday, 5 March 2024
prnewswire.com
Friday, 16 February 2024
prnewswire.com
Tuesday, 14 November 2023
prnewswire.com
Wednesday, 8 November 2023
prnewswire.com
Friday, 11 August 2023
prnewswire.com
Tuesday, 1 August 2023
prnewswire.com
Thursday, 20 July 2023
prnewswire.com
Friday, 6 January 2023
Market Watch
Monday, 14 November 2022
Zacks Investment Research
Friday, 9 September 2022
Benzinga
Monday, 29 August 2022
Benzinga
Friday, 12 August 2022
Seeking Alpha
Zacks Investment Research
Friday, 5 August 2022
PRNewsWire
Thursday, 2 June 2022
InvestorPlace
Market Watch
  • What's the price of CASI Pharmaceuticals stock today?

    One share of CASI Pharmaceuticals stock can currently be purchased for approximately $2.17.

  • When is CASI Pharmaceuticals's next earnings date?

    Unfortunately, CASI Pharmaceuticals's (CASI) next earnings date is currently unknown.

  • Does CASI Pharmaceuticals pay dividends?

    No, CASI Pharmaceuticals does not pay dividends.

  • How much money does CASI Pharmaceuticals make?

    CASI Pharmaceuticals has a market capitalization of 34.30M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 21.41% to 33.88M US dollars.

  • What is CASI Pharmaceuticals's stock symbol?

    CASI Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "CASI".

  • What is CASI Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of CASI Pharmaceuticals?

    Shares of CASI Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are CASI Pharmaceuticals's key executives?

    CASI Pharmaceuticals's management team includes the following people:

    • Dr. Wei-Wu He Ph.D. Chairman & Chief Executive Officer(age: 60, pay: $819,490)
    • Dr. Wei Zhang Ph.D. Pres & Principal Financial Officer(age: 66, pay: $715,770)
    • Dr. Alexander A. Zukiwski M.D. Executive Vice President & Chief Medical Officer(age: 68, pay: $442,780)
  • How many employees does CASI Pharmaceuticals have?

    As Jul 2024, CASI Pharmaceuticals employs 176 workers, which is 21% less then previous quarter.

  • When CASI Pharmaceuticals went public?

    CASI Pharmaceuticals, Inc. is publicly traded company for more then 29 years since IPO on 12 Jun 1996.

  • What is CASI Pharmaceuticals's official website?

    The official website for CASI Pharmaceuticals is casipharmaceuticals.com.

  • Where are CASI Pharmaceuticals's headquarters?

    CASI Pharmaceuticals is headquartered at 9620 Medical Center Drive, Rockville, MD.

  • How can i contact CASI Pharmaceuticals?

    CASI Pharmaceuticals's mailing address is 9620 Medical Center Drive, Rockville, MD and company can be reached via phone at +240 8642600.

CASI Pharmaceuticals company profile:

CASI Pharmaceuticals, Inc.

casipharmaceuticals.com
Exchange:

NASDAQ

Full time employees:

176

Industry:

Biotechnology

Sector:

Healthcare

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Rockville, Maryland.

9620 Medical Center Drive
Rockville, MD 20850

CIK: 0000895051
ISIN: US14757U2087
CUSIP: 14757U208